THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 50 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $0 | – | 63 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 63 | -94.9% | 0.00% | – |
| Q2 2016 | $1,000 | – | 1,239 | -84.1% | 0.00% | – |
| Q1 2016 | $0 | – | 7,800 | -93.2% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 114,763 | +111.3% | 0.00% | – |
| Q3 2015 | $217,000 | +228.8% | 54,303 | +230.3% | 0.00% | – |
| Q2 2015 | $66,000 | +4.8% | 16,440 | +4.6% | 0.00% | – |
| Q1 2015 | $63,000 | -30.8% | 15,721 | -48.4% | 0.00% | – |
| Q4 2014 | $91,000 | -52.1% | 30,482 | -51.5% | 0.00% | – |
| Q3 2014 | $190,000 | -15.6% | 62,806 | -15.6% | 0.00% | – |
| Q2 2014 | $225,000 | -77.3% | 74,456 | -70.0% | 0.00% | -100.0% |
| Q1 2014 | $991,000 | +725.8% | 247,796 | +727.1% | 0.00% | – |
| Q4 2013 | $120,000 | +26.3% | 29,958 | +26.1% | 0.00% | – |
| Q3 2013 | $95,000 | -35.8% | 23,765 | -15.6% | 0.00% | – |
| Q2 2013 | $148,000 | – | 28,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 270,500 | $1,288,000 | 1.11% |
| Rhenman & Partners Asset Management AB | 196,537 | $936,000 | 0.28% |
| FORTALEZA ASSET MANAGEMENT INC/ | 78,055 | $372,000 | 0.19% |
| Baker Brothers Advisors | 1,826,358 | $8,693,000 | 0.11% |
| Rotella Capital Management, Inc. | 14,600 | $69,000 | 0.08% |
| FRANKLIN STREET ADVISORS INC /NC | 69,700 | $332,000 | 0.07% |
| FEDERATED HERMES, INC. | 3,036,963 | $14,456,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 160,000 | $760,000 | 0.04% |
| SMITH ASSET MANAGEMENT GROUP LP | 200,118 | $953,000 | 0.04% |
| Princeton Alpha Management LP | 22,329 | $106,000 | 0.03% |